Decoding Sepsis
SIRS-Lab works continuously to develop and deliver unique molecular diagnostic solutions that set new performance and quality standards for sepsis diagnosis and treatment. The company's aim is to empower clinicians with an ability to identify sepsis as early as possible; to determine the causative agent and to monitor the immune response of the patient during treatment.
About SIRS-Lab
SIRS-Lab is a major player in national and European-wide sepsis networks. Company advisors are key opinion leaders in the field of inflammatory disorders and syndromes. more »Business Development
Opportunities for partnering and licensing of our products and technologies are available. more »Management
SIRS-Lab is lead by an experienced and dedicated management team supported by advisors who are opinion leaders in the IVD industry and clinical experts in critical care medicine. more »
